3rd Quarter - Report

FORBES-TATE for VIR BIOTECHNOLOGY, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Government Issues GOV

Healthcare initiatives related to novel antibody technology platform.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products.

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.